FBXO11.md
... ...
@@ -2,6 +2,8 @@
2 2
bibliography: 'morinlab.bib'
3 3
csl: 'NLM.csl'
4 4
link-citations: true
5
+nocite: |
6
+ @parryWholeExomeSequencing2013, @richterRecurrentMutationID32012, @hubschmannMutationalMechanismsShaping2021, @arthurGenomewideDiscoverySomatic2018
5 7
---
6 8
[[_TOC_]]
7 9
... ...
@@ -13,11 +15,7 @@ These mutations present a potential novel target for therapeutic intervention, p
13 15
14 16
## Relevance tier by entity
15 17
16
-|Entity|Tier|Description |
17
-|:------:|:----:|--------------------------|
18
-|![MZL](images/icons/MZL_tier2.png)|2|relevance in MZL not firmly established[@parryWholeExomeSequencing2013]|
19
-|![BL](images/icons/BL_tier1.png) |1 |high-confidence BL gene [@richterRecurrentMutationID32012]|
20
-|![DLBCL](images/icons/DLBCL_tier1.png) |1 |high-confidence DLBCL gene[@hubschmannMutationalMechanismsShaping2021; @arthurGenomewideDiscoverySomatic2018]|
18
+[[include:table1_FBXO11]]
21 19
22 20
## Mutation incidence in large patient cohorts (GAMBL reanalysis)
23 21